SING
Analyst Coverage
Cannabis Investor News in-house rating · cin-analyst-v1.0
SinglePoint earns a Neutral rating with 3/5 conviction and a 39.4 composite, reflecting a mixed profile constrained by stretched financial condition. Regulatory is the strongest pillar at 49, led by an 80 enforcement subscore and a 50 jurisdiction posture, while a 25 cadence score limits the contribution. Market ranks next at 40 despite the absence of an available quote from institutional pricing feeds. Fundamentals scores 36 as gross-margin strength is outweighed by contraction, operating losses, minimal capitalization support, and weak cash-runway scoring. Editorial contributes 30, consistent with no recent newsroom or brief activity in CIN newsroom coverage.
Licensed fundamentals data show year-over-year revenue declining by approximately 6.8%, leaving the 43.2 revenue-growth subscore below the stronger profitability contribution from gross margin. Gross margin stands near 36.5%, supporting a 60.8 subscore, but operating margin remains negative at roughly 41.8%, reflected in a 44.8 operating-margin subscore. EBITDA is negative by about $9.6 million, while the bottom line records a net loss near $28.9 million. Those figures preserve the stretched financial classification and align with a cash-runway subscore of 15 and a zero capitalization-tier contribution. Primary regulatory filings show no dated latest filing, no regulatory events across the past 90 or 180 days, and no enforcement hits. That clean enforcement record supports the leading regulatory pillar, but the missing filing date depresses cadence and limits transparency.
The clearest forward catalyst sits within regulation, where renewed filing activity can convert a clean enforcement profile into a stronger overall disclosure score. A current primary regulatory filing would establish an observable cadence, improve visibility into revenue direction and cost control, and clarify whether gross-margin resilience can translate into a less negative operating margin. With market assessment restricted by unavailable institutional pricing and editorial support limited by no recent CIN newsroom coverage, regulatory disclosure carries disproportionate influence over conviction. The single most important signal to watch is the appearance of a newly dated primary regulatory filing that restores cadence while preserving the zero-enforcement record.
- IR / PR agency
- TraDigital IR
- IR email
- investors@singlepoint.com
- IR page
- Investor relations
- Headquarters
- 2137 Phoenix, AZ 85016
- CEO
- Wil Ralston
- CFO
- Corey Lambrecht
- SEC CIK
- 0001443611
- Website
- Company website
- Market cap
- $0.0M
- Enterprise value
- $2.6M
- Price to book
- 0.07
- EV / EBITDA
- -1.84
- Revenue (TTM)
- $20.3M
- Gross profit (TTM)
- $7.4M
- EBITDA
- $-9.6M
- Operating margin
- -41.8%
- Profit margin
- -142.7%
- Rev growth YoY
- -6.8%
- Return on equity
- 0.0%
- Return on assets
- -62.0%
- EPS (TTM)
- $-3.58
- Shares outstanding
- 79.8M
- Insider ownership
- 0.0%
- Beta
- 1.01
- Full-time employees
- 60
- GICS sector
- Technology
- GICS industry
- Solar
- Filing portal
- SEC EDGAR
Help us keep coverage accurate. Submit an update for CIN editorial review.
Bullish and Bearish Analyst Opinions for SING (SING)
Cannabis Investor News aggregates analyst coverage, price targets, insider transactions, SEC filings, and financing activity for SING (SING), a cannabis-sector equity listed on OTCMKTS. Use this profile to compare bullish and bearish opinions, monitor Form 4 insider buys and sells, and review the latest quarterly results.
CIN editorial stance: Risk Elevated. Headwinds: deep drawdown. (0 bullish signals, 2 bearish signals.)
Historical Price Data
5-year weekly price history, intraday quotes, and 52-week range for SING are maintained by Cannabis Investor News and refreshed throughout the trading day.